Growth Metrics

Northwest Biotherapeutics (NWBO) Times Interest Earned (2016 - 2025)

Historic Times Interest Earned for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to -$5.46.

  • Northwest Biotherapeutics' Times Interest Earned rose 2322.0% to -$5.46 in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.6, marking a year-over-year increase of 2148.84%. This contributed to the annual value of -$8.56 for FY2024, which is 1915.02% up from last year.
  • Northwest Biotherapeutics' Times Interest Earned amounted to -$5.46 in Q3 2025, which was up 2322.0% from -$8.09 recorded in Q2 2025.
  • Northwest Biotherapeutics' Times Interest Earned's 5-year high stood at -$5.46 during Q3 2025, with a 5-year trough of -$15.37 in Q2 2021.
  • Moreover, its 5-year median value for Times Interest Earned was -$10.37 (2024), whereas its average is -$10.21.
  • In the last 5 years, Northwest Biotherapeutics' Times Interest Earned tumbled by 11604.7% in 2021 and then skyrocketed by 5226.36% in 2022.
  • Northwest Biotherapeutics' Times Interest Earned (Quarter) stood at -$9.26 in 2021, then crashed by 60.79% to -$14.89 in 2022, then rose by 18.11% to -$12.19 in 2023, then skyrocketed by 39.01% to -$7.44 in 2024, then increased by 26.52% to -$5.46 in 2025.
  • Its last three reported values are -$5.46 in Q3 2025, -$8.09 for Q2 2025, and -$10.81 during Q1 2025.